We conduct neuropsychological testing in various cardiac populations: adults with cardiovascular risk factors, coronary heart disease patients, heart failure patients, patients with atrial fibrillation, etc. (Gagnon et al., 2021, Rivard et al. 2019). We have also developed physical activity home-based programs tailored to these populations to adaot to the pandemic situation (Besnier et al. 2020).
- Rivard, L., Khairy, P., Talajic, M., Tardif, J-C., Nattel, S., Bherer, L., Black, S., Healey, J., Lanthier, S., Andrade, J., Massoud, F., Nault, I., Guertin, M-C., Dorian, P., Kouz, S., Essebag, V., Ellenbogen, K.A., Wyse, G., Racine, N., Macle, L., Mondesert, B., Dyrda, K., Tadros, R., Guerra, P., Thibault, B., Cadrin-Tourigny, J., Dubuc, M., Roux, J-F., Mayrand, H., Greiss, I., Roy, D (2019). Blinded randomized trial of anticoagulation to prevent ischemic stroke and neurocognitive impairment in AF (BRAIN-AF): Methods and design. Canadian Journal of Cardiology. Can J Cardiol. 2019 Aug;35(8):1069-1077. doi: 10.1016/j.cjca.2019.04.022
- Gagnon C, Saillant, K., Olmand, M., Gayda, M., Bouabdallaoui, N. Nigam, A., Rouleau, JL., & Bherer, L. (2021). Performances on the Montreal Cognitive Assessment Along the Cardiovascular Disease Continuum. Archives of Clinical Neuropsychology
- Besnier, F., Gayda, M., Nigam, A., Juneau, M., Bherer, L. (2020). Cardiac rehabilitation during quarantine in COVID-19 pandemic: Challenges for center-based programs. Archives of physical medicine and rehabilitation. 2020 Jun 27: S0003-9993 (20) 30388-9. Doi: 10.1016/j.apmr.2020.06.004.